Skip to main content
. 2022 Dec 20;13:100164. doi: 10.4103/jpi.jpi_54_21

Table 1.

List of reports and the corresponding data sources.

Name Data source
1. Federal reports
Number of tested samples and percent positive for COVID-19 (grouped by age) CP-LIS
Number of tested samples and percent positive CP-LIS
The overall percentage of patient visits for ILI Epic (AOE)
Associated factors with hospitalizations: Epic (admission report)
– By age
– By sex
– Age-adjusted COVID-19-associated hospitalization rates by race and ethnicity
2. State reports
Viral testing (positive, negative, total) by patient zip code/county CP-LIS
Heat map [Fig. 4] CP-LIS
3. Laboratory operational reports
3.1 Performance metrics
Cumulative COVID-19 tests ordered (number, percent) result breakdown CP-LIS
Cumulative antibody test (number, percent) results breakdown CP-LIS
Percent results reported within target TAT, average, and range of TAT [Fig. 6] CP-LIS
Average number of total tests resulted by the hour CP-LIS
Resulted tests grouped by average TAT [Fig. 7] CP-LIS
3.2 Technician performance assessment
Number of the test resulted by each technician CP-LIS
Average number of the test resulted per technician per hour compared with received tests per hour CP-LIS
3.3 Analyzer metrics
Batch size and frequency of viral testing vs. TAT (measured for Roche) [Fig. 8] CP-LIS
Batch size and frequency of viral testing vs. TAT (measured for Cepheid) CP-LIS
Batch size and frequency of antibody testing vs. TAT CP-LIS
4. Clinical reports
Antibody testing numbers, breakdown of results, and titer of antibodies CP-LIS
List of eligible antibody donors CP-LIS
Number of total transfusions
5. Research reports CP-LIS
List of pregnant patients with positive viral testing Epic
Number of patients with prior positive viral testing with first negative viral testing grouped by duration [Fig. 9] CP-LIS
Number of patients with positive viral testing with first antibody-positive test vs. days [Fig. 10] CP-LIS